Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8CRI

Crystal structure of LplA1 in complex with lipoic acid (Listeria monocytogenes)

Summary for 8CRI
Entry DOI10.2210/pdb8cri/pdb
Related6JOM
Descriptorlipoate--protein ligase, LIPOIC ACID, CHLORIDE ION, ... (6 entities in total)
Functional Keywordslipoate, salvage, anti-infectives, drug development, ligase
Biological sourceListeria monocytogenes
Total number of polymer chains2
Total formula weight77238.81
Authors
Dienemann, J.-N.,Chen, S.-Y.,Hitzenberger, M.,Sievert, M.L.,Hacker, S.M.,Prigge, S.T.,Zacharias, M.,Groll, M.,Sieber, S.A. (deposition date: 2023-03-08, release date: 2023-06-07, Last modification date: 2024-06-19)
Primary citationDienemann, J.N.,Chen, S.Y.,Hitzenberger, M.,Sievert, M.L.,Hacker, S.M.,Prigge, S.T.,Zacharias, M.,Groll, M.,Sieber, S.A.
A Chemical Proteomic Strategy Reveals Inhibitors of Lipoate Salvage in Bacteria and Parasites.
Angew.Chem.Int.Ed.Engl., 62:e202304533-e202304533, 2023
Cited by
PubMed Abstract: The development of novel anti-infectives requires unprecedented strategies targeting pathways which are solely present in pathogens but absent in humans. Following this principle, we developed inhibitors of lipoic acid (LA) salvage, a crucial pathway for the survival of LA auxotrophic bacteria and parasites but non-essential in human cells. An LA-based probe was selectively transferred onto substrate proteins via lipoate protein ligase (LPL) in intact cells, and their binding sites were determined by mass spectrometry. Probe labeling served as a proxy of LPL activity, enabling in situ screenings for cell-permeable LPL inhibitors. Profiling a focused compound library revealed two substrate analogs (LAMe and C3) as inhibitors, which were further validated by binding studies and co-crystallography. Importantly, LAMe exhibited low toxicity in human cells and achieved killing of Plasmodium falciparum in erythrocytes with an EC value of 15 μM, making it the most effective LPL inhibitor reported to date.
PubMed: 37249408
DOI: 10.1002/anie.202304533
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon